{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-000055","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.169038+00:00","generated_at":"2026-05-16T11:31:43.339107+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"confidence":"high","headline":"KALA BIO settles $10.6M Oxford debt for $2M; issues 4.6M shares to settle claims","bullets":["Paid $2M to Oxford Finance, settling ~$10.6M debt obligations in full; debt overhang removed.","Issued 900,000 shares to Baker Bros. to resolve participation rights claims under prior financing.","Issued 2,200,000 shares to LifeSci Capital for unpaid financial advisory services.","Issued 1,100,000 shares to Delaware IR to settle $600,000 consulting fee; make-whole provision.","Total 4,600,000 shares issued in private, unregistered transactions (incl. 400,000 to employees)."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-000055","json":"https://secwatch.observer/filing/0001829126-26-000055.json","markdown":"https://secwatch.observer/filing/0001829126-26-000055.md","text":"https://secwatch.observer/filing/0001829126-26-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/0001829126-26-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:31:43.339107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}